Event Details

If your company is developing diagnostics, therapeutics, vaccines, or other products to address the SARS-CoV2 pandemic, then this is the webinar for you!

The Office of Biomedical Advanced Research and Development Authority (BARDA) is working to identify and fund medical countermeasures to address the SARS-CoV2 pandemic. Life Science Washington Institute is one of 13 BARDA DRIVe Accelerators to assist companies in connecting with BARDA funding resources. Life Science WA Institute is excited to host this live, interactive webinar in collaboration with officials from BARDA DRIVe team. BARDA officials will deliver a reverse pitch about areas of interest. Have your questions ready about how to access funding and optimize your application!

Where: The webinar will be hosted virtually, and the link will be made available prior to the event.

Cost: FREE to attend!

Speakers:

• Kim Sciarretta, Ph.D., Interdisciplinary Scientist/Project Officer Biomedical Advanced Research and Development Authority (BARDA), HHS
• Kerrie Gruber-DeMarco, Ph.D., Intergovernmental & Commercial Partnership Lead, Biomedical Advanced Research & Development Authority interagency partnership builder
• Seila Selimovic, Ph.D., Program Manager, Early Notification to Act, Control and Treat (ENACT)

The event will be recorded and made available following the event.

There will be Q&A during the webinar, but to increase your chances of having your question answered, submit your questions ahead of time! Either email your question to anais@lswinstitute.org, subject: BARDA WEBINAR QUESTION or comment on the LinkedIn event page .